Shattuck Labs (STTK) EBT (2019 - 2026)
Shattuck Labs (STTK) posted quarterly EBT of -$14.8 million for Q1 2026, down 7.78% year-over-year from -$16.0 million in Q1 2025, and up 87.7% quarter-over-quarter from -$120.1 million in Q4 2025.
Analysis
Shattuck Labs (STTK) EBT (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported EBT for 8 consecutive years, with -$14.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT fell 7.78% year-over-year to -$14.8 million; the TTM figure through Mar 2026 stood at -$159.1 million (up 7.49% YoY), while the FY2025 annual figure was -$155.5 million, up 9.08% from the prior year.
- EBT improved to -$14.8 million in Q1 2026 per STTK's latest filing, from -$120.1 million in the prior quarter.
- Across five years, EBT topped out at -$11.1 million in Q3 2025 and bottomed at -$120.1 million in Q4 2025.
- Historically, EBT has averaged -$38.3 million across 5 years, with a median of -$26.1 million in 2022.
- Annual changes were most pronounced in 2023 — EBT sank 265.61% — and 2025, when it surged 57.77%.
- Shattuck Labs' EBT stood at -$26.1 million in 2022, then tumbled by 265.61% to -$95.3 million in 2023, then dropped by 20.9% to -$115.3 million in 2024, then declined by 4.16% to -$120.1 million in 2025, then soared by 87.7% to -$14.8 million in 2026.
- Business Quant data shows STTK's EBT at -$14.8 million in Q1 2026, -$120.1 million in Q4 2025, and -$11.1 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn | 542.00 Mn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | -767.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -644.37 Mn |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn | 312.46 Mn |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn | 177.81 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - | 81.49 Mn |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Shattuck Labs | 888.99 Mn | 888.99 Mn | - | -15.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.13 Mn |
| Mar 31, 2026 | -14.77 Mn |
| Dec 31, 2025 | -13.37 Mn |
| Sep 30, 2025 | -10.72 Mn |
| Jun 30, 2025 | -12.23 Mn |
| Mar 31, 2025 | -13.70 Mn |
| Dec 31, 2024 | -19.64 Mn |
| Sep 30, 2024 | -17.92 Mn |
| Jun 30, 2024 | -22.96 Mn |
| Mar 31, 2024 | -20.04 Mn |
| Dec 31, 2023 | -18.95 Mn |
| Sep 30, 2023 | -28.60 Mn |
| Jun 30, 2023 | -22.75 Mn |
| Mar 31, 2023 | -21.66 Mn |
| Dec 31, 2022 | -26.28 Mn |
| Sep 30, 2022 | -25.23 Mn |
| Jun 30, 2022 | -27.66 Mn |
| Mar 31, 2022 | -24.17 Mn |
| Dec 31, 2021 | 7.92 Mn |
| Sep 30, 2021 | -17.33 Mn |